Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.96% is in line with its 5-year average of -29.54%, around the middle of its 5-year range (-45.08%–-14.07%).
As of the fiscal period ended Tuesday, June 30, 2026. 9.95% above its 12-month average of -32.16%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.96%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.96%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-32.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-28.74%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-29.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+9.95%
CURRENT VS 3Y AVG
-0.74%
CURRENT VS 5Y AVG
+1.99%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.40%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-444.72%
vs the sector median at left
Beam Therapeutics Inc.
Market Cap
$2.51B
Return on Invested Capital (ROIC)
-28.96%
TTM Avg
-32.16%
3Y Avg
-28.74%
5Y Avg
-29.54%
Market Cap
$2.74B
Return on Invested Capital (ROIC)
5.87%
TTM Avg
7.96%
3Y Avg
-0.22%
5Y Avg
-9.17%
Market Cap
$2.14B
Return on Invested Capital (ROIC)
-49.78%
TTM Avg
-43.13%
3Y Avg
-47.40%
5Y Avg
-42.10%
Market Cap
$1.73B
Return on Invested Capital (ROIC)
10.03%
TTM Avg
-6.49%
3Y Avg
-7.14%
5Y Avg
-3.83%
Market Cap
$1.72B
Return on Invested Capital (ROIC)
-54.45%
TTM Avg
-54.60%
3Y Avg
-46.39%
5Y Avg
-38.46%
Market Cap
$1.00B
Return on Invested Capital (ROIC)
-7.32%
TTM Avg
-21.18%
3Y Avg
-91.27%
5Y Avg
-61.58%
Market Cap
$472.39M
Return on Invested Capital (ROIC)
-5.29%
TTM Avg
-5.58%
3Y Avg
-6.88%
5Y Avg
-5.95%
Market Cap
$459.30M
Return on Invested Capital (ROIC)
8.75%
TTM Avg
20.32%
3Y Avg
26.86%
5Y Avg
29.17%
Market Cap
$397.55M
Return on Invested Capital (ROIC)
-25.26%
TTM Avg
-29.12%
3Y Avg
-26.65%
5Y Avg
-26.65%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | $2.51B | -28.96% | -32.16% | -28.74% | -29.54% |
| TransMedics Group, Inc. (TMDX)vs › | $2.74B | 5.87% | 7.96% | -0.22% | -9.17% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.14B | -49.78% | -43.13% | -47.40% | -42.10% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | 10.03% | -6.49% | -7.14% | -3.83% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.72B | -54.45% | -54.60% | -46.39% | -38.46% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -7.32% | -21.18% | -91.27% | -61.58% |
| NeoGenomics, Inc. (NEO)vs › | $472.39M | -5.29% | -5.58% | -6.88% | -5.95% |
| NRC Health (NRC)vs › | $459.30M | 8.75% | 20.32% | 26.86% | 29.17% |
| Shoulder Innovations, Inc. (SI)vs › | $397.55M | -25.26% | -29.12% | -26.65% | -26.65% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.03M | -3699.99% | -104.88% | -89.50% | -74.29% |
ROIC
-29.0%
ROE
-8.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.96% |
| 2026-03-31 | -26.43% |
| 2025-12-31 | -27.43% |
| 2025-09-30 | -41.32% |
| 2025-06-30 | -36.64% |
| 2025-03-31 | -32.50% |
| 2024-12-31 | -45.08% |
| 2024-09-30 | -18.17% |
| 2024-06-30 | -17.02% |
| 2024-03-31 | -15.49% |
| 2023-12-31 | -14.07% |
| 2023-09-30 | -37.22% |
| 2023-06-30 | -33.33% |
| 2023-03-31 | -32.47% |
| 2022-12-31 | -30.27% |
| 2022-09-30 | -28.16% |
| 2022-06-30 | -24.11% |
| 2022-03-31 | -21.69% |
| 2021-12-31 | -31.07% |
| 2021-09-30 | -34.97% |
| 2021-06-30 | -44.02% |
| 2021-03-31 | -51.37% |
| 2020-12-31 | -37.77% |
| 2020-09-30 | -50.88% |
| 2020-06-30 | -37.70% |
| 2020-03-31 | -30.87% |
| 2019-12-31 | -58.59% |
| 2019-09-30 | -41.39% |
| 2019-06-30 | -34.50% |
| 2018-12-31 | -32.34% |
